BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1392420)

  • 1. Acquired protein S deficiency.
    Kemkes-Matthes B
    Clin Investig; 1992 Jun; 70(6):529-34. PubMed ID: 1392420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 3. On the clinical significance of acquired antithrombin deficiency.
    Sørum Y; Handeland GF; Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):797-805. PubMed ID: 6083956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy.
    Takahashi H; Tatewaki W; Wada K; Shibata A
    Clin Chim Acta; 1989 Jun; 182(2):195-208. PubMed ID: 2528431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired protein S and antithrombin III deficiency caused by nephrotic syndrome: an unusual cause of graft thrombosis.
    Siddiqi FA; Tepler J; Fantini GA
    J Vasc Surg; 1997 Mar; 25(3):576-80. PubMed ID: 9081142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic disease--critical evaluation of laboratory investigation.
    Malm J; Laurell M; Nilsson IM; Dahlbäck B
    Thromb Haemost; 1992 Jul; 68(1):7-13. PubMed ID: 1514176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.
    Pabinger I; Schneider B
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):742-8. PubMed ID: 8640401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
    Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
    Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-plasmin inhibitor and its deficiency states.
    Saito H
    J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog.
    Ritt MG; Rogers KS; Thomas JS
    J Am Anim Hosp Assoc; 1997; 33(5):385-91. PubMed ID: 9278113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
    Alving BM; Comp PC
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.
    Mehls O; Andrassy K; Koderisch J; Herzog U; Ritz E
    J Pediatr; 1987 Jun; 110(6):862-7. PubMed ID: 3585601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired antithrombin III deficiency].
    Müller G
    Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboembolism. The clinical significance of antithrombin III].
    Schramm W
    Internist (Berl); 1984 Feb; 25(2):88-92. PubMed ID: 6368458
    [No Abstract]   [Full Text] [Related]  

  • 19. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.